Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy (semaglutide) reduces appetite significantly, but the medicine alone is not a shortcut — most people who see the strongest results combine it with consistent lifestyle changes that work alongside the way it acts on the body. If your weight loss on Wegovy has slowed or feels lower than expected, the answer usually isn't a higher dose; it's a look at what's happening the other 167 hours of the week. These are prescription-only medicines assessed by a clinician before they're prescribed, and any change to your treatment plan should be discussed with your prescriber.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most common misconception our prescribers hear is that semaglutide works regardless of everything else. It doesn't, and it was never licensed on that basis. The UK approval covers use alongside a reduced-calorie diet and increased physical activity, not instead of them. What the medicine genuinely does is make the lifestyle changes easier: hunger signals quiet down, portion sizes naturally shrink, and food noise fades for many people. That creates an opening. The people who make the most of it are those who step into that opening deliberately.
So if you're asking how to boost weight loss on Wegovy, the honest answer is: the injection shifts your appetite, but your protein plate, your sleep, and how much you move still matter enormously. What weight loss looks like on Wegovy varies considerably between individuals precisely because those background factors are different for everyone. Recognising that is the first step toward changing it.
One practical check you can do in under a minute: scan the last three days of meals and ask whether protein featured at every one. Most people on GLP-1 treatment who are losing less than expected are under-eating protein, not over-eating calories. That single variable explains a lot.
When appetite falls sharply (as it often does after a dose increase) the temptation is to eat very little. The problem is that very low calorie intake without adequate protein leads the body to draw on muscle as well as fat. Less muscle means a slower resting metabolism, which makes subsequent loss harder and recovery from plateaus slower.
UK dietary guidance does not set a specific target for people on GLP-1 treatment, and your prescriber or a registered dietitian is the right person to advise on your individual needs. As a general principle, NHS guidance on healthy weight emphasises building meals around protein and fibre sources rather than reducing volume alone. Prioritising protein at each meal (eggs, fish, lean meat, legumes, dairy) helps preserve muscle while your body loses fat.
Hydration is also underestimated. Semaglutide slows gastric emptying, which can blunt thirst signals. Mild dehydration is sometimes mistaken for a plateau when it's a different problem entirely. The timeline for seeing results on Wegovy often looks different once basic things like fluid intake are corrected.
Cardiovascular exercise burns calories in the moment; resistance training changes the equation over time by preserving or building the muscle mass that keeps your metabolism running. For people on semaglutide, the combination of both is supported by the general evidence on weight management, and the NICE guidance for weight-management medicines specifically recommends increased physical activity alongside any pharmacological treatment.
You don't need a gym. Bodyweight exercises three times a week, or progressive walking with hills or a weighted rucksack, produce meaningful changes. The goal isn't heroic effort at the start, it's consistency. Many people find that as appetite settles on Wegovy, energy levels actually improve, making it easier to be more active than before.
For context on the evidence base, the strongest results seen on Wegovy in clinical settings consistently belonged to participants who maintained structured lifestyle programmes alongside the medicine. The STEP 1 trial, published in the New England Journal of Medicine, paired semaglutide with a reduced-calorie diet and counselling, the 15% average reduction reflects that combined approach.
Weight loss is partly hormonal, and sleep deprivation disrupts those hormones directly, specifically ghrelin (which drives hunger) and leptin (which signals fullness). Poor sleep can partially undermine what semaglutide is trying to do. Six hours or fewer consistently is associated with slower loss in weight-management research. This is rarely the first thing people address, but it's often the thing that breaks a plateau.
Chronic stress elevates cortisol, which promotes fat storage particularly around the abdomen and can trigger cravings for high-energy foods even when appetite is reduced. Neither sleep nor stress is a simple fix, but naming them as physiological contributors (not willpower failures) is the right framing.
Plateaus are normal. The body adapts its energy expenditure as weight falls, which means a period of slower loss is not a sign the medicine has stopped working. The reasons Wegovy may seem to stall are well understood, and most resolve with patience or a review of the factors above rather than a dose change. If you're unsure whether your progress reflects the expected trajectory, it helps to understand how long it typically takes to see weight loss on Wegovy before drawing conclusions, and if you want a clearer picture of the timeline from the very first dose, our guide on how long Wegovy takes to work walks through what to expect week by week.
Finally, if you're wondering whether a different medicine might suit your situation better, our overview of weight-loss treatments covers the options available in the UK. And if you'd like a clinical eye on your specific circumstances, the team at our clinical oversight page explains how our prescribers approach exactly these questions. Wegovy is a prescription-only medicine; any adjustment to your plan deserves a conversation with a clinician, not a guess. You can start a free consultation with our GPhC-registered prescribers whenever you're ready.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.